Prospective Grant of a Co-Exclusive License: Natural Plant Extracts From Incense Cedar as Pest Control Agents and Methods for Their Use, 53321-53322 [2010-21643]

Download as PDF Federal Register / Vol. 75, No. 168 / Tuesday, August 31, 2010 / Notices Name of Committee: National Institute of Mental Health Initial Review Group; Interventions Committee for Adult Disorders. Date: October 12–13, 2010. Time: 8:30 a.m. to 5 p.m. Agenda: To review and evaluate grant applications. Place: Hyatt Regency Bethesda, One Bethesda Metro Center, 7400 Wisconsin Avenue, Bethesda, MD 20814. Contact Person: David I. Sommers, PhD, Scientific Review Officer, Division of Extramural Activities, National Institute of Mental Health, National Institutes of Health, 6001 Executive Blvd., Room 6154, MSC 9606, Bethesda, MD 20892–9606, 301–443–7861, dsommers@mail.nih.gov. Name of Committee: National Institute of Mental Health Initial Review Group; Mental Health Services in MH Specialty Settings. Date: October 15, 2010. Time: 8:30 a.m. to 5 p.m. Agenda: To review and evaluate grant applications. Place: The Dupont Hotel, 1500 New Hampshire Avenue, NW., Washington, DC 20036. Contact Person: Marina Broitman, PhD, Scientific Review Officer, Division of Extramural Activities, National Institute of Mental Health, NIH, Neuroscience Center, 6001 Executive Blvd., Room 6153, MSC 9608, Bethesda, MD 20892–9608, 301–402–8152, mbroitma@mail.nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.242, Mental Health Research Grants; 93.281, Scientist Development Award, Scientist Development Award for Clinicians, and Research Scientist Award; 93.282, Mental Health National Research Service Awards for Research Training, National Institutes of Health, HHS) Dated: August 25, 2010. Jennifer S. Spaeth, Director, Office of Federal Advisory Committee Policy. [FR Doc. 2010–21662 Filed 8–30–10; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health srobinson on DSKHWCL6B1PROD with NOTICES National Institute of Allergy and Infectious Diseases; Notice of Closed Meetings Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of the following meetings. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant VerDate Mar<15>2010 16:33 Aug 30, 2010 Jkt 220001 applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Institute of Allergy and Infectious Diseases Special Emphasis Panel, Partnerships for Biodefense (Vaccines/Immunotherapeutics 3). Date: September 27, 2010. Time: 11 a.m. to 5 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health. 6700B Rockledge Drive, Room 3254, Bethesda, MD 20892 (Telephone Conference Call). Contact Person: Nancy Lewis Ernst, PhD, Scientific Review Official, Scientific Review Program, Division of Extramural Activities, National Institutes of Health/NIAID, 6700B Rockledge Drive, MSC 7616, Bethesda, MD 20892–7616, 301–451–7383, nancy.ernst@nih.gov. Name of Committee: National Institute of Allergy and Infectious Diseases Special Emphasis Panel, Partnerships for Biodefense (Vaccines/Immunotherapeutics 1). Date: October 8, 2010. Time: 11 a.m. to 5 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, 6700B Rockledge Drive, Room 3254, Bethesda, MD 20892 (Telephone Conference Call). Contact Person: Nancy Lewis Ernst, PhD, Scientific Review Official, Scientific Review Program, Division of Extramural Activities, National Institutes of Health/NIAID, 6700B Rockledge Drive, MSC 7616, Bethesda, MD 20892–7616, 301–451–7383, nancy.ernst@nih.gov. Name of Committee: National Institute of Allergy and Infectious Diseases Special Emphasis Panel, Partnerships for Biodefense (Vaccines/Immunotherapeutics 2). Date: October 12, 2010. Time: 11 a.m. to 5 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, 6700B Rockledge Drive, Room 3254, Bethesda, MD 20892 (Telephone Conference Call). Contact Person: Nancy Lewis Ernst, PhD, Scientific Review Official, Scientific Review Program, Division of Extramural Activities, National Institutes of Health/NIAID, 6700B Rockledge Drive, MSC 7616, Bethesda, MD 20892–7616, 301–451–7383, nancy.ernst@nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.855, Allergy, Immunology, and Transplantation Research; 93.856, Microbiology and Infectious Diseases Research, National Institutes of Health, HHS) Dated: August 25, 2010. Jennifer S. Spaeth, Director, Office of Federal Advisory Committee Policy. [FR Doc. 2010–21647 Filed 8–30–10; 8:45 am] BILLING CODE 4140–01–P PO 00000 Frm 00051 Fmt 4703 Sfmt 4703 53321 DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Prospective Grant of a Co-Exclusive License: Natural Plant Extracts From Incense Cedar as Pest Control Agents and Methods for Their Use Centers for Disease Control and Prevention (CDC), Department of Health and Human Services (HHS). ACTION: Notice. AGENCY: This is a notice in accordance with 35 U.S.C. 209(e) and 37 CFR 404.7(a)(1)(i) that the Technology Transfer Office of the Centers for Disease Control and Prevention (CDC), located within the Department of Health and Human Services (HHS), is contemplating the grant of worldwide co-exclusive licenses to practice the inventions embodied in the patents referred to below to Allylix, Incorporated and Valent BioSciences Corporation, having places of business in San Diego, CA and Libertyville, IL, respectively. The patent rights in these inventions have been assigned to the government of the United States of America. The patent(s) to be licensed are: SUMMARY: U.S. Pat. No. 7,629,387, ‘‘Compounds for Pest Control and Methods for Their Use,’’ issued December 8, 2009; and U.S. Pat. No. 7,129,271, ‘‘Compounds for Pest Control and Methods for Their Use,’’ issued October 31, 2006; and all related foreign patent applications. Inventors: Marc C. Dolan, Nicholas A. Panella, Joseph J. Karchesy, Gary O. Maupin. [CDC Tech. ID No. I–024–00]; and U.S. Pat. No. 7,230,033, ‘‘Pest Control Compositions and Methods for Their Use,’’ issued June 12, 2007. Inventors: Marc C. Dolan, Nicholas A. Panella, Gabrielle E. B. Dietrich, Joseph J. Karchesy, Gary O. Maupin [CDC Tech. ID No. I–028–04]. Additional rights to be licensed are: ‘‘Natural Plant Extracts from Incense Cedar as Pest Control Agents and Methods for Their Use,’’ submitted February 21, 2008. Inventors: Marc C. Dolan, Nicholas A. Panella, and Joseph J. Karchesy [CDC Tech. ID No. I–019–08]. Patent Status: Various. Earliest Priority Date: December 8, 2000. The prospective co-exclusive licenses will be royalty-bearing and will comply with the terms and conditions of 35 U.S.C. 209 and 37 CFR 404.7. Technology This technology identifies biologically active fractions of essential oil of Alaska yellow cedar which are insecticidal and acaricidal. These natural compounds were found to be active for up to 11 E:\FR\FM\31AUN1.SGM 31AUN1 53322 Federal Register / Vol. 75, No. 168 / Tuesday, August 31, 2010 / Notices weeks against the tick vector, Ixodes scapularis; the mosquito vector, Aedes aegypti; and the flea vector, Xenopsylla cheopsis. ADDRESSES: Requests for copies of these patent applications, patents, and technology disclosures, inquiries, comments, and other materials relating to the contemplated license should be directed to Andrew Watkins, J.D., Ph.D., Director, Technology Transfer Office, Centers for Disease Control and Prevention (CDC), 4770 Buford Highway, Mailstop K–79, Atlanta, GA 30341, telephone: (770) 488–8600; facsimile: (770) 488–8615. Applications for a license filed in response to this notice will be treated as objections to the grant of the contemplated licenses. Only written comments and/or applications for a license which are received by CDC within thirty days of this notice will be considered. Comments and objections submitted in response to this notice will not be made available for public inspection, and, to the extent permitted by law, will not be released under the Freedom of Information Act, 5 U.S.C. 552. Dated: August 25, 2010. Tanja Popovic, Deputy Associate Director for Science, Centers for Disease Control and Prevention. [FR Doc. 2010–21643 Filed 8–30–10; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HOMELAND SECURITY United States Immigration and Customs Enforcement Agency Information Collection Activities: Extension of an Existing Information Collection; Comment Request 30-Day Notice of Information Collection for Review; National Security Entry-Exit Registration System (NSEERS), OMB No. 1653–0036. srobinson on DSKHWCL6B1PROD with NOTICES ACTION: The Department of Homeland Security, U.S. Immigration and Customs Enforcement (USICE), will submit the following information collection request for review and clearance in accordance with the Paperwork Reduction Act of 1995. The information collection was previously published in the Federal Register on May 5, 2010 Vol. 75 No. 86, 24721, allowing for a 60 day public comment period. ICE received nine (9) comments during this comment period. The purpose of this notice is to allow an additional 30 days for public comments. Comments are encouraged VerDate Mar<15>2010 16:33 Aug 30, 2010 Jkt 220001 and will be accepted for thirty days September 30, 2010. Interested persons are invited to submit written comments on the proposed information collection to the Office of Information and Regulatory Affairs, Office of Management and Budget. Comments should be addressed to OMB Desk Officer, for United States Immigration and Customs Enforcement, Department of Homeland Security, and sent via electronic mail to oira_submission@omb.eop.gov or faxed to (202) 395–5806. Written comments and suggestions from the public and affected agencies concerning the proposed collection of information should address one or more of the following four points: (1) Evaluate whether the proposed collection of information is necessary for the proper performance of the functions of the agency, including whether the information will have practical utility; (2) Evaluate the accuracy of the agencies’ estimate of the burden of the proposed collection of information, including the validity of the methodology and assumptions used; (3) Enhance the quality, utility, and clarity of the information to be collected; and (4) Minimize the burden of the collection of information on those who are to respond, including through the use of appropriate automated, electronic, mechanical, or other technological collection techniques or other forms of information technology, e.g., permitting electronic submission of responses. Overview of This Information Collection (1) Type of Information Collection: Extension of an existing information collection. (2) Title of the Form/Collection: National Security Entry-Exit Registration System (NSEERS). (3) Agency form number, if any, and the applicable component of the Department of Homeland Security sponsoring the collection: There is no form associated with this collection which is sponsored by U.S. Immigration and Customs Enforcement. (4) Affected public who will be asked or required to respond, as well as a brief abstract: Primary: Individuals and Households. This information collection requires certain nonimmigrant aliens to make specific reports to ICE approximately 30 days after arrival; every 12 months after arrival; upon certain events, such as change of address, employment or school; and at the time they leave the United States. PO 00000 Frm 00052 Fmt 4703 Sfmt 4703 (5) An estimate of the total number of respondents and the amount of time estimated for an average respondent to respond: 58,000 responses at 30 minutes (.50 hours) per response. (6) An estimate of the total public burden (in hours) associated with the collection: 29,000 annual burden hours. Requests for additional information about information should be sent via email to forms.ice@dhs.gov with ‘‘NSEERS’’ in the subject line. Dated: August 24, 2010. Joseph M. Gerhart, Chief, Records Management Branch, U.S. Immigration and Customs Enforcement, Department of Homeland Security. [FR Doc. 2010–21627 Filed 8–30–10; 8:45 am] BILLING CODE 9111–28–P DEPARTMENT OF HOMELAND SECURITY United States Immigration and Customs Enforcement Agency Information Collection Activities: New Information Collection; Comment Request 30-Day Notice of New Information Collection for Review; ICE Mutual Agreement between Government and Employers (IMAGE), OMB No. 1653–NEW. ACTION: The Department of Homeland Security, U.S. Immigration and Customs Enforcement (USICE), will submit the following information collection request for review and clearance in accordance with the Paperwork Reduction Act of 1995. The information collection was previously published in the Federal Register on June 11, 2010 Vol. 75 No. 112 33319, allowing for a 60 day public comment period. No comments were received on this information collection. The purpose of this notice is to allow an additional 30 days for public comments. Comments are encouraged and will be accepted for thirty days September 30, 2010. Interested persons are invited to submit written comments on the proposed information collection to the Office of Information and Regulatory Affairs, Office of Management and Budget. Comments should be addressed to OMB Desk Officer, for United States Immigration and Customs Enforcement, Department of Homeland Security, and sent via electronic mail to oira_submission@omb.eop.gov or faxed to (202) 395–5806. Written comments and suggestions from the public and affected agencies concerning the proposed collection of E:\FR\FM\31AUN1.SGM 31AUN1

Agencies

[Federal Register Volume 75, Number 168 (Tuesday, August 31, 2010)]
[Notices]
[Pages 53321-53322]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2010-21643]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Prospective Grant of a Co-Exclusive License: Natural Plant 
Extracts From Incense Cedar as Pest Control Agents and Methods for 
Their Use

AGENCY: Centers for Disease Control and Prevention (CDC), Department of 
Health and Human Services (HHS).

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: This is a notice in accordance with 35 U.S.C. 209(e) and 37 
CFR 404.7(a)(1)(i) that the Technology Transfer Office of the Centers 
for Disease Control and Prevention (CDC), located within the Department 
of Health and Human Services (HHS), is contemplating the grant of 
worldwide co-exclusive licenses to practice the inventions embodied in 
the patents referred to below to Allylix, Incorporated and Valent 
BioSciences Corporation, having places of business in San Diego, CA and 
Libertyville, IL, respectively. The patent rights in these inventions 
have been assigned to the government of the United States of America. 
The patent(s) to be licensed are:

    U.S. Pat. No. 7,629,387, ``Compounds for Pest Control and 
Methods for Their Use,'' issued December 8, 2009; and U.S. Pat. No. 
7,129,271, ``Compounds for Pest Control and Methods for Their Use,'' 
issued October 31, 2006; and all related foreign patent 
applications. Inventors: Marc C. Dolan, Nicholas A. Panella, Joseph 
J. Karchesy, Gary O. Maupin. [CDC Tech. ID No. I-024-00]; and U.S. 
Pat. No. 7,230,033, ``Pest Control Compositions and Methods for 
Their Use,'' issued June 12, 2007. Inventors: Marc C. Dolan, 
Nicholas A. Panella, Gabrielle E. B. Dietrich, Joseph J. Karchesy, 
Gary O. Maupin [CDC Tech. ID No. I-028-04].
    Additional rights to be licensed are: ``Natural Plant Extracts 
from Incense Cedar as Pest Control Agents and Methods for Their 
Use,'' submitted February 21, 2008. Inventors: Marc C. Dolan, 
Nicholas A. Panella, and Joseph J. Karchesy [CDC Tech. ID No. I-019-
08].

    Patent Status: Various.
    Earliest Priority Date: December 8, 2000.
    The prospective co-exclusive licenses will be royalty-bearing and 
will comply with the terms and conditions of 35 U.S.C. 209 and 37 CFR 
404.7.

Technology

    This technology identifies biologically active fractions of 
essential oil of Alaska yellow cedar which are insecticidal and 
acaricidal. These natural compounds were found to be active for up to 
11

[[Page 53322]]

weeks against the tick vector, Ixodes scapularis; the mosquito vector, 
Aedes aegypti; and the flea vector, Xenopsylla cheopsis.

ADDRESSES: Requests for copies of these patent applications, patents, 
and technology disclosures, inquiries, comments, and other materials 
relating to the contemplated license should be directed to Andrew 
Watkins, J.D., Ph.D., Director, Technology Transfer Office, Centers for 
Disease Control and Prevention (CDC), 4770 Buford Highway, Mailstop K-
79, Atlanta, GA 30341, telephone: (770) 488-8600; facsimile: (770) 488-
8615.
    Applications for a license filed in response to this notice will be 
treated as objections to the grant of the contemplated licenses. Only 
written comments and/or applications for a license which are received 
by CDC within thirty days of this notice will be considered. Comments 
and objections submitted in response to this notice will not be made 
available for public inspection, and, to the extent permitted by law, 
will not be released under the Freedom of Information Act, 5 U.S.C. 
552.

    Dated: August 25, 2010.
Tanja Popovic,
Deputy Associate Director for Science, Centers for Disease Control and 
Prevention.
[FR Doc. 2010-21643 Filed 8-30-10; 8:45 am]
BILLING CODE 4163-18-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.